# Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients.

> **NCT06126029** · PHASE2 · UNKNOWN · sponsor: **Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh** · enrollment: 68 (estimated)

## Conditions studied

- Knee Osteoarthritis
- Metformin

## Interventions

- **DRUG:** Metformin 500 Mg extended release Oral Tablet
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT06126029
- **Lead sponsor:** Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-15
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06126029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06126029, "Effect of Metformin as Add-on Therapy to Ibuprofen on Disease Activity in Knee Osteoarthritis Patients.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06126029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*